The FDA Actions During the Pandemic

The FDA Actions During the Pandemic

Supressing Medicine

Ivermectin

November 10, 2021 Notice of FDA Action (Aaron Siri) asking the Post Office to intercept shipments of ivermectin.

Covid-19 Incentive Payments

Incentive payments, estimated to be circa $100,000 per patient, may go some way to explain inflated case numbers, inflated death numbers, continued use of ventilators and remdesivir (despite horrendous adverse effect levels for both), and the push for mandatory vaccines among health workers. GreenMedInfo article.

Study: Most N.Y. COVID Patients on Ventilators Died

By Robert Preidt HealthDay Reporter

WEDNESDAY, April 22, 2020 (HealthDay News) – The largest analysis of hospitalized U.S. COVID-19 patients to date finds that most did not survive after being placed on a mechanical ventilator.

The study included the health records of 5,700 COVID-19 patients hospitalized between March 1 and April 4 at facilities overseen by Northwell Health, New York State's largest health system.

Among the 2,634 patients for whom outcomes were known, the overall death rate was 21%, but it rose to 88% for those who received mechanical ventilation, the Northwell Health COVID-19 Research Consortium reported.

The new findings “provide a crucial early insight into the front-line response to the COVID-19 outbreak in New York,” Dr. Kevin Tracey, president and CEO of the Feinstein Institutes for Medical Research, said in a Northwell Health news release.

The findings also add fuel to the notion that ventilators may sometimes do more harm than good for patients battling for life with severe COVID-19. ¹⁾